|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
on1319073945 |
003 |
OCoLC |
005 |
20240808213014.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
220520s2022 si o 000 0 eng d |
040 |
|
|
|a YDX
|b eng
|e rda
|e pn
|c YDX
|d GW5XE
|d EBLCP
|d OCLCF
|d SFB
|d UKAHL
|d OCLCQ
|d OCLCO
|d OCLCQ
|
019 |
|
|
|a 1319198260
|a 1319221015
|a 1321801501
|
020 |
|
|
|a 9789811662263
|q (electronic bk.)
|
020 |
|
|
|a 9811662266
|q (electronic bk.)
|
020 |
|
|
|z 9789811662256
|
020 |
|
|
|z 9811662258
|
024 |
7 |
|
|a 10.1007/978-981-16-6226-3
|2 doi
|
035 |
|
|
|a (OCoLC)1319073945
|z (OCoLC)1319198260
|z (OCoLC)1319221015
|z (OCoLC)1321801501
|
050 |
|
4 |
|a RC271.I45
|
072 |
|
7 |
|a MED062000
|2 bisacsh
|
049 |
|
|
|a HCDD
|
245 |
0 |
0 |
|a Immuno-oncology crosstalk and metabolism /
|c Muzafar Ahmad Macha, Ajaz Ahmad Bhat, Nissar Ahmad Wani, editors.
|
264 |
|
1 |
|a Singapore :
|b Springer,
|c [2022]
|
264 |
|
4 |
|c ©2022
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
520 |
|
|
|a This book discusses the novel metabolic cross-talk between immune and tumor cells in the tumor microenvironment that promotes their growth and progression. It also describes deregulated metabolism in cancer cells that promotes suppressive and cancer cell-favourable microenvironment. Further, the book provides novel insights on the metabolic changes in immune cells that promote tumor cell growth and survival. In turn, it also reviews the involvement of immuno-onco metabolic cross-talk in the development of resistance to chemo-radiation therapy (CRT) in tumor cells. Lastly, it also explores the potential of immuno-oncology metabolism as a therapeutic approach against tumor cells.
|
505 |
0 |
|
|a 1 Cancer Metabolism and Aggressive Tumor Behaviour -- 2 Immune Cell Metabolism and Function -- 3 Cancer Cell Metabolism Effecting Immune function -- 4 Immune Cell Metabolites as Fuel for Cancer Cells -- 5 Immuno-Onco metabolism and Resistance to Therapy -- 6 Targeting Immuno-Onco metaolism in Cancers -- 7 Timing of the major metabolic switches in immune cell activation and differentiation during cancer development.
|
588 |
0 |
|
|a Online resource; title from PDF title page (SpringerLink, viewed May 31, 2022).
|
650 |
|
0 |
|a Immunotherapy.
|
650 |
|
0 |
|a Cancer
|x Treatment.
|
650 |
|
0 |
|a Cell metabolism.
|
650 |
|
7 |
|a Cancer
|x Treatment
|2 fast
|
650 |
|
7 |
|a Cell metabolism
|2 fast
|
650 |
|
7 |
|a Immunotherapy
|2 fast
|
650 |
|
7 |
|a Immunoteràpia.
|2 thub
|
650 |
|
7 |
|a Terapèutica.
|2 thub
|
650 |
|
7 |
|a Càncer.
|2 thub
|
650 |
|
7 |
|a Metabolisme cel·lular.
|2 thub
|
655 |
|
7 |
|a Llibres electrònics.
|2 thub
|
700 |
1 |
|
|a Macha, Muzafar Ahmad,
|e editor.
|
700 |
1 |
|
|a Bhat, Ajaz Ahmad,
|e editor.
|
700 |
1 |
|
|a Wani, Nissar Ahmad,
|e editor.
|
776 |
0 |
8 |
|c Original
|z 9811662258
|z 9789811662256
|w (OCoLC)1264139577
|
856 |
4 |
0 |
|u https://holycross.idm.oclc.org/login?auth=cas&url=https://link.springer.com/10.1007/978-981-16-6226-3
|y Click for online access
|
903 |
|
|
|a SPRING-BIOMED2022
|
994 |
|
|
|a 92
|b HCD
|